EQUASENS And TUBIZE-FIN Have A High Dividend Yield And Return On Equity In The Healthcare Sector.

(VIANEWS) – EQUASENS (EQS.PA) is among this list of stock assets with the highest dividend rate and return on equity on the Healthcare sector.

Financial Asset Price Forward Dividend Yield Return on Equity
EQUASENS (EQS.PA) €61.20 1.87% 27.25%
TUBIZE-FIN (TUB.BR) €71.50 1.2% 4.93%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. EQUASENS (EQS.PA)

1.87% Forward Dividend Yield and 27.25% Return On Equity

Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id. MOBILITY, a back-office management software; pandaLAB Pro, an instant messaging solution; Id. VENTE, an HAS-certified drug database; Id. COMMANDE, an order management module; dispensing robots; Services Ségur id; id. DOSAGE, a dosage management and printing module; multimeds reconditioning robot; compliance monitoring module; home delivery module; home equipment rental management module; Visiodroits module; and Website connector. The company also provides id. DESK, an informative and interactive dashboard; id. UP!, a real-time monitoring and control application of id management software; id. EASYQ, a queue management solution; Miaterapia; Id. SHOW, an application for managing real-time communications on pharmacy screens; Pharmaweb; TsGatePro; LMO, a dispensary business software; and LGO, a dispensary management software. In addition, it offers DOMILINK HAD software; mobiSOINS mobility tool; MEMORialis, support software for alzheimer's monitoring teams; HOSPILINK, an hospital information system applications; HOSPILINK DPI, a computerized patient file; HOSPILINK LOOKUP Big Data; eNephro solutions; NOVIAcare solutions; KAP&LINK2, a contact chip card reader terminal and NFC reader; eS-KAP-Ad, a connected nomadic tool incorporating software; KAP-INSIDE, a mobile terminal; and TI-KAP allowing access to contact and contactless cards. Further, the company provides AUTHENTICATOR, a patented authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; ExpressVitale; MédiStory, that automates the transfer of invoicing to the healthcare professional's accounting. Additionally, it offers medical telesecretarial services for healthcare professionals, as well as equipment lease financing solutions. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

Earnings Per Share

As for profitability, EQUASENS has a trailing twelve months EPS of €3.05.

PE Ratio

EQUASENS has a trailing twelve months price to earnings ratio of 20.07. Meaning, the purchaser of the share is investing €20.07 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.25%.

More news about EQUASENS.

2. TUBIZE-FIN (TUB.BR)

1.2% Forward Dividend Yield and 4.93% Return On Equity

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. The company is based in Brussels, Belgium.

Earnings Per Share

As for profitability, TUBIZE-FIN has a trailing twelve months EPS of €2.

PE Ratio

TUBIZE-FIN has a trailing twelve months price to earnings ratio of 35.75. Meaning, the purchaser of the share is investing €35.75 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.93%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TUBIZE-FIN’s stock is considered to be oversold (<=20).

More news about TUBIZE-FIN.

Leave a Reply

Your email address will not be published. Required fields are marked *